Shenzhen Kangtai Biological Products Receives Drug Registration Certificate for Sabin Strain Polio Inactivated Vaccine

Stock News09-15

Shenzhen Kangtai Biological Products Co.,Ltd. (300601.SZ) announced that its wholly-owned subsidiary, Beijing Minhai Biotechnology Co., Ltd., has received a Drug Registration Certificate issued by the National Medical Products Administration. The registered product is the Sabin Strain Polio Inactivated Vaccine (Vero Cells), which is intended for the prevention of acute infectious diseases caused by poliovirus.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment